The above chart presents the market trend analysis for murli krishna pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 1500 and a transaction weight of 0.
Suppliers
hayat pharmaceutical industries co.plc. nile street, al-rajeeb, p.o.box 1564, amman- 11118, sdnf jordan
Buyers
murli krishna pharma
POLs
——
PODs
jnpt
Supply area
India
Purchas area
India
Weight
——
Amount
134045.9135
Hs code
29333990
Product tags
import,lansoprazole,pharmaceutical raw material,rejected
Product description
PHARMACEUTICAL RAW MATERIAL ; LANSOPRAZOLE PALLETS- 8.5% (RE-IMPORT OF REJECTED GOODS EXPORT VIDE SB NO-6929674 DT-31/1PHARMACEUTICAL RAW MATERIAL
Expand
Trade date
2025/07/09
B/L No.
0341418
Suppliers
hayat pharmaceutical industries co.plc. nile street, al-rajeeb, p.o.box 1564, amman- 11118, sdnf jordan
Buyers
murli krishna pharma
POLs
——
PODs
jnpt
Supply area
India
Purchas area
India
Weight
——
Amount
12566.8044
Hs code
29333990
Product tags
import,lansoprazole,pharmaceutical raw material,rejected
Product description
PHARMACEUTICAL RAW MATERIAL ; LANSOPRAZOLE PALLETS- 8.5% (RE-IMPORT OF REJECTED GOODS EXPORT VIDE SB NO-7702937 DT-29/0PHARMACEUTICAL RAW MATERIAL
Expand
Trade date
2025/07/02
B/L No.
1332870
Suppliers
rx solution limitedmladost 2, bl. 258b, building a, entrance 1, floor 0, sofia 1799 bulgaria
Buyers
murli krishna pharma
murli krishna pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as orlistat,bat,pancreatin.
According to the 52wmb.com global trade database, as of 2026-02-27, the company has completed 6023 international trades,
with its main trading regions covering china,spain,mexico etc.
The core products include HS29329990,HS30049099,HS35079079 etc,
often transported via sahar air cargo acc inbom4,port bombay air, port nhavasheva innsa1 etc,
and its main trading partners are inke s.a.,shandong new time pharmacetical co,disproquimex s.de r.l.de c.v..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on murli krishna pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.